Kanghong Pharmaceutical announced that the company recently received the “Drug Registration Certificate” for ibutinib capsules issued by the State Drug Administration. The drug specification is 140 mg, and the registered classification is chemical class 4. The approval number is Sinopharm standard H20266472. Indications include mantle cell lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma, and Fahrenheit macroglobulinemia. This approval further expands the company's product layout and pipeline in the field of anti-tumor drugs.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.